The North America Probiotics Dietary Supplements Market is expected to witness market growth of 7.1% CAGR during the forecast period (2021-2027).
Probiotics dietary supplements market is further boosted by the rise in demand for weight management. In addition, factors such as growing obesity rates and increased demand for weight management solutions, with a high emphasis on satiety, fat-burning, and calorie-consuming characteristics.
The demand for probiotic products is expected to be boosted by the fact that Probiotics can strike an ideal balance between good and bad bacteria in the body for smooth functioning. In addition, probiotics are beneficial in the treatment of diseases like urogenital infections, intestinal inflammation, and antibiotic-associated diarrhea, by fighting against bad bacteria
The high prevalence of digestive issues, bloating, and low resistance to infections is due to the lack of appropriate diet, stress levels, and age. These issues have encouraged many people in the region to embrace different probiotic supplements, thereby fuelling the growth of the regional probiotics dietary supplements market. The growth of the regional market is expected to be boosted by the increased preference for middle-class people to maintain digestive health that motivates them to accept different functional foods including probiotic supplements. Hence, these factors have been instrumental in the increased demand for probiotics dietary supplements in the North American market.
The US market dominated the North America Probiotics Dietary Supplements Market by Country in 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $2,849.1 million by 2027. The Canada market is anticipated to grow at a CAGR of 9.5% during (2021 - 2027). Additionally, The Mexico market is expected to showcase CAGR of 8.6% during (2021 - 2027).
Based on Form, the Probiotics Dietary Supplements market is segmented into Capsules, Chewables & Gummies, Powders, Tablets & Softgels, and Others. Based on End User, the market is segmented into Adults, Geriatric, Children, and Infants. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke DSM N.V., DuPont de Nemours, Inc., Chr. Hansen holding A/S, Archer Daniels Midland Company, Probi AB, BioGaia AB, Vitakem Nutraceutical, Inc., and ProbioFerm.
Scope of the Study
Market Segments Covered in the Report:
By Form
- Capsules
- Chewables & Gummies
- Powders
- Tablets & Softgels
- and Others
By End User
- Adults
- Geriatric
- Children
- Infants
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Koninklijke DSM N.V.
- DuPont de Nemours, Inc.
- Chr. Hansen holding A/S
- Archer Daniels Midland Company
- Probi AB
- BioGaia AB
- Vitakem Nutraceutical, Inc.
- ProbioFerm
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Companies Mentioned
- Koninklijke DSM N.V.
- DuPont de Nemours, Inc.
- Chr. Hansen holding A/S
- Archer Daniels Midland Company
- Probi AB
- BioGaia AB
- Vitakem Nutraceutical, Inc.
- ProbioFerm
Methodology
LOADING...
